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Agrin Acts via a MuSK Receptor Complex
David J. Glass,* David C. Bowen,* Trevor N. Stitt,* maintaining the postsynaptic specialization by anchor-
ing it to both the overlying basal lamina and the underly-Czeslaw Radziejewski,* JoAnne Bruno,*
Terence E. Ryan,* David R. Gies,* Sonal Shah,* ing cytoskeleton.
Nerve-derived signals appear to induce postsynapticKaren Mattsson,* Steven J. Burden,²
Peter S. DiStefano,* David M. Valenzuela,* differentiation by at least two mechanisms (Hall and
Sanes, 1993). First, these signals can induce redistribu-Thomas M. DeChiara,* and George D. Yancopoulos*
*Regeneron Pharmaceuticals, Inc. tion of pre-existing molecules that are initially expressed
throughout the surface of the myofiber. Second, nerve-777 Old Saw Mill River Road
Tarrytown, New York 10591 derived signals appear able to induce localized tran-
scription of certain genes only by the subsynaptic nuclei²Molecular Neurobiology Program
Skirball Institute underlying the NMJ. Many questions still remain con-
cerning theprecise natureof the nerve-derived inductiveNew York University Medical Center
New York, New York 10016 signals. One key nerve-derived factor appears to be a
protein, termed agrin, that was discovered for its ability
to cause clustering of pre-existing AChRs on the surface
of cultured myotubes (Godfrey et al., 1984; McMahan,
Summary 1990; Rupp et al., 1991; Tsim et al., 1992). Agrin has
subsequently been shown to cocluster a number of syn-
Formation of the neuromuscular junction depends aptic components along with AChRs on the surface of
upon reciprocal inductive interactions between the cultured myotubes (Wallace, 1989). Evidence suggests
developing nerve and muscle, resulting in the precise that although agrin may play important organizing roles
juxtaposition of a differentiated nerve terminal with a for the endplate, it cannot mediate all aspects of post-
highly specialized patch on the muscle membrane, synaptic differentiation; for example,agrin isnot thought
termed the motor endplate. Agrin is a nerve-derived to be responsible for inducing synapse-specific tran-
factor that can induce molecular reorganizations at scription of certain genes, but rather a factor alterna-
the motor endplate, but the mechanism of action of tively referred to as ARIA or neuregulin is implicated in
agrin remains poorly understood. MuSK is a receptor these inductions (Burden et al., 1995).
tyrosine kinase localized to the motor endplate, seem- Agrin is a 200 kDa protein that can be subdivided
ingly well positioned to receive a key nerve-derived into a number of distinct domains. The N-terminal half
signal. Mice lacking either agrin or MuSK have recently contains nine follistatin-like repeats that bear homology
been generated and exhibit similarly profound defects
to Kazal-type protease inhibitor domains, while the
in their neuromuscular junctions. Here we demon-
C-terminal half contains four epidermal growth factor±
strate that agrin acts via a receptor complex that in-
like repeats and three regions homologous to the G
cludes MuSK as well as a myotube-specific accessory
domains of laminin (Rupp et al., 1991; Tsim et al., 1992).
component.
The clustering activity of agrin has been mapped to
the C-terminal region; while the full-length form of agrin
interacts tightly with the extracellular matrix, the C-ter-Introduction
minal region can be made in soluble form and is referred
to as c-agrin (Ruegg et al., 1992; Tsim et al., 1992; FernsSignals from motor neurons to muscle, which regulate
et al., 1993; Hoch et al., 1994). A number of differentmuscle contraction as well as other aspects of muscle
forms of agrin have been discovered, encoded by alter-function, are transmitted across a synaptic structure
natively spliced transcripts (Ferns et al., 1992; Ruegg etknown as the neuromuscular junction (NMJ) (Hall and
al., 1992; Tsim et al., 1992; Hoch et al., 1993). TheSanes, 1993). Formation of this structure depends upon
C-terminal region of agrin can contain variable insertionsreciprocal inductive interactions between the devel-
at two critical sites, referred to as the Y and Z sites, thatoping nerve and muscle that result in the precise juxta-
can affect the clustering ability of the agrin (Ferns etposition of a differentiated nerve terminal with a tiny
al., 1992, 1993; Ruegg et al., 1992; Hoch et al., 1994);and highly specialized patch on the muscle membrane,
differential splicing results in transcripts encodingreferred to as the motor endplate. This postsynaptic
agrins with different combinations of these insertions.specialization is designed to optimize recognition of
Importantly, expression of these different agrin formsnerve-derived signals, and it markedly differs from the
are restricted to either muscle or nerve (Ruegg et al.,rest of the myofiber surface at both the ultrastructural
1992; Hoch et al., 1993). A neuronal-specific insertionand molecular levels. Molecularly, the postsynaptic sur-
at the Z position is absolutely required for the clusteringface is characterized by an extraordinarily dense cluster-
ability of soluble c-agrin, and agrins with an eight aminoing of receptors for nerve-derived signals. The most
acid insertion at this position are at least 10,000-foldextensively studied of these are the receptors for the
more active than agrins lacking an insert at this positionneurotransmitter acetylcholine (AChRs), which regulate
(Ruegg et al., 1992; Ferns et al., 1993). Muscle-derivedthe electrical activity and contractile state of the muscle.
agrins lack the insertion at the Z position, and thus areThe postsynaptic membrane is also characterized by a
unique molecular scaffold that appears responsible for not potent clustering agents. A four amino acid insertion
Cell
514
at the Y position causes a modest additional increase required for agrin responses (Wallace et al., 1991; Qu
and Huganir, 1994; Wallace, 1994, 1995; Ferns et al.,in the activity of agrins having an insertion at the Z
position, and the Y insertion also seems to be involved 1996). We recently identified a receptor-like tyrosine ki-
nase specific to the skeletal muscle lineage, which wein the binding of agrin to heparin and proteoglycans
(Ferns et al., 1993; Hoch et al., 1994). termed MuSKÐfor muscle-specific kinase (Valenzuela
et al., 1995). MuSK is expressed very early in the muscleA variety of data are consistent with the notion that
the in vitro clustering actions of agrin reflect similar lineage and becomes highly localized to the motor end-
plate as muscle matures; following denervation, MuSKorganizing roles for agrin during the in vivo formation
of the NMJ (McMahan, 1990). Most important among once again becomes widely and highly expressed
throughout the myofiber, as do AChRs (Valenzuela etthese are the findings that the highly active forms of
agrin are exclusively made by neurons and are depos- al., 1995). The synapse-specific localization of MuSK
suggested that it might play a critical role at the NMJ,ited in the synaptic basal lamina (Ruegg et al., 1992;
Hoch et al., 1993), and that antibodies to agrin block and this was confirmed following the generation and
characterization of mice homozygous for a MuSK genenerve-induced clustering of AChRs on cultured myo-
tubes (Reist et al., 1992). The precise mechanism of disruption (DeChiara et al., 1996 [this issue of Cell]).
Mice lacking MuSK die at birth, owing to an inability toaction of agrin remains a mystery (Sealock and Froeh-
ner, 1994). Agrin induces intracellular tyrosine phos- breathe, and are generally immobile, resulting from the
fact that these mice lack NMJs. Every aspect of NMJphorylations, including of the b-subunit of the AChR,
and inhibitors of tyrosine phosphorylation block agrin- formation appears to be blocked in these mice, with the
apparent loss of both presynaptic differentiation andmediated clustering (Wallace et al., 1991; Qu and Hu-
ganir, 1994; Wallace, 1994, 1995; Ferns et al., 1996). synapse-specific transcription, as well as of postsynap-
tic organization.Intriguing recent findings have revealed that agrin can
directly bind to an extrinsic peripheral membrane pro- The defects in mice lacking MuSK appear much more
profound than those that might have been predicted totein, known as a-dystroglycan, via its laminin-like do-
mains (Bowe et al., 1994; Campanelli et al., 1994; Gee result from disruption of the agrin signaling pathway,
since agrin has mostly been characterized for its or-et al., 1994; Sugiyama et al., 1994). a-dystroglycan is
part of a protein complex, hereinafter referred to as the ganizing actions on the postsynaptic side of the NMJ
and was not thought to be required either for regulatingdystroglycan complex, that seems to provide for crucial
anchoring between the extracellular basal lamina and presynapticdifferentiation, or for inducing synapse-spe-
cific transcription. However, recent generation of micethe underlying cytoskeleton (Fallon and Hall, 1994). Ex-
trasynaptically, the dystroglycan complex binds laminin lacking agrin revealed that NMJ formation in these mice
is as profoundly disrupted as it is in mice lacking MuSKin the extracellular matrix and associates with the actin
scaffold via a spectrin-like protein known as dystrophin, (Gautam et al., 1996 [this issue of Cell ]); in both cases,
it can be postulated that the effects on presynaptic dif-whereas at the synapse agrin can substitute for laminin
and utrophin replaces dystrophin (Fallon and Hall, 1994). ferentiation and on synapse-specific transcription indi-
rectly result from primary postsynaptic defects. Thus,In addition, the dystroglycan complex is apparently cou-
pled to AChRs by a 43 kDa cytoplasmic protein known the striking similarities between mice lacking agrin and
mice lacking MuSK suggest that agrin, acting via theas rapsyn (Noakes et al., 1993; Apel et al., 1995).
Despite the findings that agrin can bind directly to MuSK receptor, is required for initiating all aspects of
NMJ formation. Here we demonstrate that agrin binds,a-dystroglycan and that the dystroglycan complex is
coupled to AChRs via rapsyn, the role of a-dystroglycan and does indeed act via, a MuSK receptor complex.
as an agrin receptor remains unclear (Sealock and
Froehner, 1994). Dystroglycan could be a required com-
Resultsponent of the functional agrin receptor that is responsi-
ble for initiating the signaling response, and might even
Agrin Fails to Induce AChR Clusteringbe directly involved in activating signaling pathways.
in Myotubes Lacking MuSKAlthough known components of the dystroglycan com-
The localization of MuSK to the NMJ, together with theplex lack obvious signaling capabilities, it has been sug-
absence of NMJs in mice lacking MuSK (MuSK2/2 mice),gested, for example, that they might be associated with
inspired us to ask whether MuSK is required for respon-cytoplasmic tyrosine kinases. Alternatively, dystrogly-
sivity to agrin. To test this, we first isolated myoblastscan could play a more ancillary role, serving to concen-
from newborn MuSK2/2 or from control pups, attemptedtrate agrin near a signaling-competent receptor or acting
to differentiate them into myotubes in culture, and thento couple such a receptor, via agrin, to some of its
assayed for their responsiveness to agrin. Myoblaststargets.
from both the control and MuSK2/2 mice were able toTransmembrane receptors with intrinsic tyrosine
fuse and form long, twitching myotubes in culture. To-kinase activity, known as receptor tyrosine kinases
gether with the observation that skeletal muscle appears(RTKs), play key roles in many biological responses
rather normal in MuSK2/2 mice, these findings indicate(Schlessinger and Ullrich, 1992). Although such recep-
that MuSK is not critical for early muscle developmenttors are generally known for mediating mitogenic or
and myoblast fusion. On the otherhand, MuSK appearedsurvival responses to traditional growth factors or neu-
to be absolutely required for AChR clustering in re-rotrophic factors, it has been speculated that the or-
sponse to agrin. After stimulation with the most activeganizing function of agrin might be mediated by an RTK,
particularly since tyrosine phosphorylation seems to be form of c-agrin, containing both the 4 and 8 amino acid
Agrin Acts via the MuSK Receptor
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Figure 1. Agrin Induces AChR Clustering in
Myotubes from Control but Not MuSK2/2
Mice
Myotubes derived from control and
MuSK2/2 mice were treated overnight with
varying concentrations of agrin4,8, stained
with rhodamine-conjugated a-bungarotoxin
to label surface AChRs, and then either pho-
tographed at 643 magnification (shown here
at z253) under rhodamine optics ([A], chal-
lenge with 100 nM agrin depicted) or sub-
jected to AChR cluster quantitation ([B], each
point represents the mean 6 SEM of 40 myo-
tube segments) as described in the Experi-
mental Procedures. Total AChRs on the
myotubes before agrin treatment were deter-
mined by binding with [125I]a-bungarotoxin
([C], each bar represents the mean 6 SEM
CPM bound per microgram of total cell pro-
tein (control, n 5 6; MuSK2/2, n 5 5) as de-
scribed in Experimental Procedures.
insertions (c-agrin4,8), AChR clusters were evident only
in the myotubes from control mice (Figure 1A). While
clusters were induced in normal myotubes with as
little as 1 nM c-agrin4,8, no clustering was observed in
MuSK2/2 myotubes even after increasing the concentra-
tion of c-agrin4,8 to as high as 100 nM (Figure 1B). Lack
of detectable clustering was not due to the absence of
AChRs, since myotubes from MuSK2/2 mice expressed
similar numbers of AChR on their surface as did myo-
tubes from control mice (Figure 1C). Thus, MuSK ap-
pears to be absolutely required for AChR clustering in
response to agrin.
Agrin Induces Prominent and Rapid Tyrosine
Phosphorylation of MuSK
The inability of agrin to induce AChR clustering in myo-
tubes from MuSK2/2 mice demonstrates that MuSK is
required for agrin responsiveness and is consistent with
the possibility that MuSK serves as the functional agrin
receptor. However, since clustering occurs over a period
of hours, these results are also consistent with thepossi-
bility that MuSK acts much further downstream in the
agrin signaling pathway. To begin to distinguish be-
tween these possibilities, we took advantage of the fact
that RTKs become rapidly autophosphorylated on tyro-
sine upon challenge with their cognate ligand. We de-
cided to assay four of theknown forms of soluble agrinÐ
which exhibit differing AChR clustering activities (Ferns
Figure 2. c-agrin4,8 and c-agrin0,8 Specifically Induce Rapid Tyrosineet al., 1992, 1993; Ruegg et al., 1992; Hoch et al., 1994)Ð
Phosphorylation of MuSK Receptorsfor their ability to induce phosphorylation of the MuSK
C2C12 and primary rat myoblasts were differentiated into myotubesreceptor.Phosphorylation was assessed onthe endoge-
and stimulated with conditioned media from COS cells transfectednous MuSK receptor that is highly expressed in myotube
with a plasmid control (Mock) or plasmids encoding the variouscultures, obtained by differentiating either the C2C12
forms of soluble agrin, with conditioned media containing neuregu-
mouse myoblast cell line (Valenzuela et al., 1995) or lin, or with purified bFGF or insulin, as labeled. Stimulations were
primary rat myoblasts. Strikingly, soluble agrins con- for 10 min using 10 nM of the various factors, except as indicated
in (C) and (D). Following factor challenges, the cells were lysed andtaining the 8 amino acid insert at position Z (c-agrin4,8
subjected to immunoprecipitations (I. P.) for either the MuSK orand c-agrin0,8), which are the forms capable of inducing
ErbB3 receptors as indicated, then immunoblotted for phosphotyro-AChR clustering, were also the formsthat induced prom-
sine levels. Only agrins containing the 8 amino acid insert at the Zinent tyrosine phosphorylation of MuSK (Figure 2A). The
position, but not other factors, could induce MuSK phosphorylation
agrin most active in clustering (c-agrin4,8) was also most (A). Agrin could not induce phosphorylation of another muscle re-
active in inducing MuSK phosphorylation (Figure 2A). In ceptor, ErbB3 (B). MuSK phosphorylation occurred at low agrin
concentrations (C) and very rapidly in response to agrin (D).contrast, the soluble agrins lacking the 8 amino acid
Cell
516
insert (c-agrin4,0 and c-agrin0,0), which cannot induce
AChR clustering, also could not induce MuSK phosphor-
ylation (Figure 2A).
The specificity of action of agrin was further explored
by comparing its activity to growth factors known to
have receptors on muscle. Of the several such factors
tested, including insulin, fibroblast growth factor (FGF),
and ARIA/neuregulin, only agrin could induce phosphor-
ylation of MuSK (Figure 2A); since FGF also induces
AChR clustering on myotubes (Peng et al., 1991), these
results also indicate that MuSK phosphorylation is spe-
cific to agrin responses and not just to agents capable
of inducing clustering. Furthermore, while such factors
could be shown to induce phosphorylation of their own
RTKs on myotubes (e.g., neuregulin induces phosphory-
lation of its cognate RTK, ErbB3, Figure 2B), agrin could
only activate MuSK and not other RTKs (Figure 2B).
The activation of a RTK by its cognate ligand typically
tends to occur rapidly, and we could demonstrate that
agrin induces tyrosine phosphorylation of MuSK with
kinetics similar to those seen for well-characterized
RTK/ligand systems (e.g., Kaplan et al., 1991); induction
was detectable by one minute, peaked within the first
Figure 3. Agrin Can Not Detectably Bind to the Isolated Ectodomainfive minutes, and remained elevated for over an hour
of MuSK(Figure 2D and datanot shown). The tyrosine phosphory-
Agrin was assayed for its binding to immobilized MuSK±Fc or to anlation of MuSK also occurred using agrin at concentra-
immoblized agrin-specific monoclonal antibody (mAb), each cou-tions similar to those noted for other ligands that act on
pled to a BIAcore sensorchip surface (A); bindings to the MuSK±Fc
RTKs (Ip et al., 1993), with phosphorylation detectable surface were also done in the presence 2 mM Ca21 or heparin (0.01
using 1 nM agrin (Figure 2C). mg/ml), as indicated, while bindings to the antibody surface were
Together, the requirement of MuSK for agrin respon- also competed with excess soluble monoclonal antibody or
MuSK±Fc (each at 25 mg/ml), as indicated. Reciprocally, binding ofsiveness, the ability of agrin to induce rapid and promi-
soluble MuSK±Fc or monoclonal antibody to immobilized agrin wasnent MuSK phosphorylation, the specificity of agrin for
assayed by first binding conditioned media transfected with a plas-MuSK as compared to other factors tested, and the
mid control (Mock) or a plasmid encoding c-agrin4,8 (cAg4,8) to nitro-precise correlationof agrin forms active in AChR cluster- cellulose, followed by detection using either the soluble MuSK±Fc
ing assays and in MuSK phosphorylation assays con- or the agrin-specific monoclonal antibody, as indicated (B); TrkB±Fc
tinue to support the notion that MuSK serves as the detection of nitrocellulose-immobilized BDNF served as an addi-
tional control.functional agrin receptor.
Agrin Does Not Directly Bind to an Isolated the MuSK surface could be seen (Figure 3A). Further-
more, while binding to the antibody surface was specifi-MuSK Ectodomain
If MuSK is indeed the functional agrin receptor, we cally competable by excess soluble antibody added to
the agrin-containing media, the binding was not com-would expect to be able to demonstrate binding of agrin
to MuSK. In an attempt to demonstrate such binding, petable by excess soluble MuSK±Fc (Figure 3A). Since
agrin activity requires calcium (Bowe and Fallon, 1995),we first constructed an expression construct encoding
a fusion protein between the ectodomain of rat MuSK and because some heparin-binding factors require hep-
arin to bind to their receptors (Goldfarb, 1990), we alsoand the Fc portion of human immunoglobulin G1 (desig-
nated MuSK±Fc), and then produced and purified the attempted binding in thepresence of calcium or heparin;
in neither case was binding to the MuSK surface ob-fusion protein. Similar receptor±Fc fusions have pre-
viously been used to characterize binding between served (Figure 3A).
Next, we tried to demonstrate binding of MuSK andRTKs and their ligands (e.g., Davis et al., 1994; Stitt et
al., 1995). In a first approach, we used MuSK±Fc together agrin by attempting to use MuSK±Fc to detect agrin
immobilized onto nitrocellulose. In contrast to our con-with BIAcore biosensor technology (Fagerstam, 1991;
Johnsson et al., 1991). The BIAcore technology allows trol experiments, in which immobilized brain-derived
neurotrophic factor (BDNF) was easily detected by anfor the direct and quantitative measure of binding of
soluble ligands to receptors coupled onto a sensor chip. Fc fusion of its cognate receptor (TrkB±Fc) (Figure 3D),
and in which immobilized agrin was easily detected byRecombinant MuSK±Fc was covalently coupled to a
surface on the BIAcore sensor chip, and as a control, the agrin-specific monoclonal antibody (Figure 3B), im-
mobilized agrin could not be detected by MuSK±Fc (Fig-a monoclonal antibody specific for rat agrin was also
coupled to a separate surface on the sensor chip; media ure 3C).
The negative binding results described above demon-containing c-agrin4,8 was then passed over the two sur-
faces. While robust binding of the agrin to the antibody strate that the isolated MuSK receptor is not sufficient
to bind agrin. Thus, despite the plethora of functionalsurface was easily detected, no binding of the agrin to
Agrin Acts via the MuSK Receptor
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data indicating that agrin acts via MuSK, MuSK may not
directlyserve as a receptor for agrin. Alternatively,MuSK
may require additional components or modifications
that are required for it to bind and respond to agrin.
Agrin Activates MuSK in a Cell Context±Dependent
Fashion: Requirement for a Myotube-Specific
Accessory Component
Based on the results described above, we decided to
consider the possibility that the agrin±MuSK interaction
requires additional components. To further explore this
possibility, we determined the cell context dependency
Figure 4. Agrin Can Only Induce MuSK Phosphorylation in the Con-for agrin activation of MuSK; we reasoned that if an
text of a Differentiated Myotube: Evidence for a Myotube-Specificaccessory component were required, it might be specifi-
Accessory Componentcally expressed only on cells normally responding to
Agrin-inducible phosphorylation of an introduced chick MuSK re-agrin. Thus, we ectopically expressed full-length cDNAs
ceptor was evaluated in a clone of C2C12 myoblasts stablyencoding rat, human, and chicken MuSK in fibroblasts
transfected with a chick MuSK expression vector. The introduced
and assayed for whether these MuSK receptors could chick MuSK is expressed regardless of whether this C2C12 clone is
be inducibly phosphorylated by agrin. When expressed undifferentiated (Undif) or differentiated into myotubes (Dif) (middle
in fibroblasts, none of the three species of MuSK could gel), in contrast to the endogenous mouse MuSK, which is only
expressed in differentiated cells (bottom gel). However, the chickbe phosphorylated in response to agrin (data not
MuSK can only be inducibly phosphorylated in response to agrinshown). While this data supported the possibility that
when it is assayed in differentiated myotubes (upper gel). The chickMuSK requires an accesssory myotube-specific compo-
MuSK displays the same specificity for activation by the various
nent to respond to agrin, it was also possible that our agrin isoforms (each at 10 nM for 10 min) as does the endogenous
cDNAs encoded MuSK variants that could not respond mouse MuSK (compare transfected chick MuSK and endgenous
mouse MuSK in upper gel).to agrin; this was a particularly worrisome possibility
since there are multiple differently spliced versions of
the MuSK transcript (Valenzuela et al., 1995), we did not
A Receptor Complex Can Be Demonstratedknow which of the formswere normally agrin responsive,
between Agrin, MuSK and a Myotube-Specificand our cDNAsonly accounted for a subset of the variant
Accessory Component(s)forms. Thus, we decided to express our cDNAs in my-
Altogether, the above data indicate that agrin requires
oblasts so that we could verify that they could mediate
MuSK to mediate clustering and that agrin activates
responses to agrin when expressed in the right context.
MuSK very rapidly, but that agrin does not directly bind
For this purpose we chose to express the chicken MuSK
to a purified MuSK ectodomain and can only activate
(D. J. G. et al., unpublished data) in the mouse C2C12
MuSK in the context of a myotube. These findings are
myoblast cell line, since the chicken MuSK could easily
consistent with the possibility that MuSK is a requisite
be distinguished from the endogenous mouse MuSK
part of an agrin receptor complex, but that although
based on size and by using particular antibodies. When MuSK providesa key signaling function for this complex,
expressed in undifferentiated myoblasts, the chicken it requires another component(s) to bind to agrin. Similar
MuSK did not undergo phosphorylation in response to types of receptor complexes have been described for
any isoforms of agrin (Figure 4, upper gel, lanes labeled other ligands. Perhaps some of the best characterized
Undif), just as it did not undergo phosphorylation in examples include the receptor complexes for ciliary
fibroblasts; undifferentiated C2C12 cells do not express neurotrophic factor (CNTF) and its cytokine relatives
appreciable amounts of endogenous MuSK (Figure 4, (Davis et al., 1993; Stahl and Yancopoulos, 1993). To
lower gel, lanes labeled Undif) (see also Valenzuela et interact with its two-signal transducing b receptor com-
al., 1995), so we could not compare activation of the ponents, gp130 and LIFRb, CNTF must first bind to its
endogenous mouse MuSK in myoblasts. Upon differen- a receptor component, known as CNTFRa. CNTFRa
tiation into myotubes, the introduced chicken MuSK was serves no signaling role, and is in fact linked to the
as effectively activated by agrin as was the endogenous surface via a glycosylphosphatidylinositol linkage and
mouse MuSK (Figure 4, upper gel, lanes labeled Diff); thus has no cytoplasmic domain. The receptor complex
both introduced and endogenous MuSK had identical for CNTF is built in step-wise fashion: CNTF first binds
profiles of responsivity to the various forms of agrins, to CNTFRa; this initial complex can then bind to and
with activations mediated only by forms having the 8 recruit a single b component; finally, a complete com-
amino acid insert at the Z position. Thus our cDNAs plex forms that involves b component dimerization,
encode MuSK proteins that are perfectly competent to which is required for signal initiation (Figure 5A). In the
undergo agrin-induced phosphorylation, but they can final complex, CNTF seems to make contacts with all
only be activated by agrin in the context of a differenti- three receptor components. Interestingly, receptor com-
ated myotube, consistent with the notion that agrin acti- plexes for CNTF can be built in solution using just the
vation of MuSK requires a myotube-specific accessory soluble ectodomains of the various components. Fur-
component that is not expressed in fibroblasts or undif- thermore, if just one of the receptor components is
linked to the surface, a receptor complex can be builtferentiated myoblasts.
Cell
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Figure 5. Relevant Models for the Agrin/MuSK Receptor Complex
(A) Schematic representation depicting the step-wise assembly of
the multicomponent receptor complex for ciliary neurotrophic factor
(CNTF); b1, gp130; b2, LIFRb.
(B) Schematic depiction of the use of solubleb receptor components Figure 6. Evidence for an Agrin/MuSK Receptor Complex Utilizing
(Fc-tagged) to build a CNTF receptor complex attached to the cell a Myotube-Specific Accessory Component
surface via only one of its components, the nonsignaling a compo-
(A) Formation of agrin/MuSK complexeson the surface of myotubes:nent; surface binding of the soluble b components can be detected
undifferentiated (Undiff.) or myotube-differentiated (Diff.) C2C12using antibodies recognizing the Fc tag.
cells were assayed for their ability to bind either MuSK±Fc or a
(C) Schematic representation of one of several possible models of
control receptor±Fc fusion (TrkB±Fc), in the absence or presence
the MuSK receptor complex for agrin, depicting requirement for a
of various agrin isoforms (provided in conditioned media from tran-
myotube-associated specificity component (MASC) and possible
sient COS transfections); specific binding of MuSK±Fc to the myo-
interactions to additional components that may be required for sig-
tube surface, which is enhanced by exogenously provided agrin, is
naling orcoupling to various effectors orsubstrates; these couplings
suggested to involve complexes analogous to those depicted in
may be mediated extracellularly (for example, via agrin binding to
Figure 5B.the dystroglycan complex) or intracellularly (for example, via interac-
(B) Direct binding of agrin to MuSK is demonstrated by cross-linkingtions of SH2 domain±containing proteins to phosphorylated tyro-
analysis. Radiolabeled agrin (a recombinant C-terminal fragment ofsines on MuSK).
human agrin, termed hAgrin4,8) at 1 nM was chemically cross-linked
to the surface of myotubes. Following cross-linking, lysates were
immunoprecipitated with a MuSK-specific antibody (left lane). Thearound it using soluble versions of the other compo-
cross-linking was also done in the presence of excess (150 nM)nents, but only in a CNTF-dependent fashion (Fig-
unlabeled agrin (middle lane), while the immunoprecipitation wasure 5B).
also done in the presence of excess peptide (corresponding to that
If agrin binds to MuSK in a receptor complex, we used to generate the antibody) to block the MuSK precipitation;
reasoned that we might be able to manipulate this com- positions of the agrin/MuSK complex, as well as of various forms
plex in much the same way the CNTF receptor complex of unbound monomeric and dimeric agrin (see text), are indicated.
can be manipulated. To explore the possibility that myo- (C) Inhibition of agrin-induced AChR clustering by MuSK±Fc: agrin-
induced AChR-clustering (using 10 nM c-agrin4,8) was performed ontubes specifically express an accessory component(s)
C2C12 myotube cultures in the presence of varying concentrationsrequired for agrin to bind MuSK (Figure 5C), we decided
of soluble MuSK±Fc or a control receptor±Fc fusion (Ret±Fc); theto test whether we could specifically build a receptor
soluble MuSK±Fc specifically inhibits, presumably by forming inac-complex on the surface of myotubes, but not on other
tive complexes on the cell surface with agrin and the myotube-
cells, using agrin together with a soluble version of the specific accessory component.
MuSK receptor to complex to the putative accessory
component(s) on the surface of myotubes. Confirming
this possibility, we found that the binding of soluble MuSK complex formation, forms of c-agrin without this
insert can also form these complexes. The ability ofMuSK±Fc to the surface of cells can be increased using
agrin, but only on the surface of differentiated myotubes all the soluble forms to promote complex formation,
including those lacking the 8 amino acid insert for activ-and not on the surface of fibroblasts or myoblasts (Fig-
ure 6A). These data demonstrate that complexes can ity, may be related to previous findings that matrix-
bound forms of agrins lacking the Z insert can activateform between agrin and MuSK, but only in the presence
of a myotube-associated specificity component, MASC clustering (Ferns et al., 1992). Thus, although soluble
agrins lacking inserts at the Z position do not seem(as suggested in Figure 5C). Interestingly, although
forms of c-agrin containing the 8 amino acid insert at capable of signaling, they may be able to form partial
complexes, while matrix-associated forms of thesethe Z position are best able to promote agrin-dependent
Agrin Acts via the MuSK Receptor
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same agrins can proceed to form complete signaling- Discussion
competent complexes. Interestingly, ligands for the EPH
family of RTKs provide an example of ligands that bind MuSK Is a Requisite Subunit of the Agrin Receptor
but do not activate their receptors when presented in Complex but Requires a Myotube-Specific
soluble form, but which can act as potent activators Accessory Component
when bound to the cell surface (Davis et al., 1994); delib- The localization of MuSK to the NMJ (Valenzuela et al.,
erate clustering of the soluble ligands can allow them 1995), together with the observations that MuSK2/2 mice
to activate as well, suggesting that the role of surface- have profound NMJ defects similar to those seen in
attachment is to allow for ligand-clustering (Davis et al., agrin-deficient mice (DeChiara et al., 1996), initially sug-
1994). gested that MuSK might serve as the functional receptor
In the absence of added agrin, the MuSK±Fc exhibited for nerve-derived agrin. In this manuscript we have pro-
much higher binding to myotube surfaces than did sev- vided data demonstrating that, although MuSK alone is
eral control receptor±Fc fusion proteins (Figure 6A, data not sufficient to mediate responses to agrin, it serves
shown for TrkB±Fc); the MuSK±Fc, however, displayed as a crucial component of the receptor complex for agrin
similar agrin-independent binding to both myoblast and (see Figure 5C). Our finding here that myotubes derived
fibroblasts as did control receptor±Fc proteins (Figure from MuSK2/2 mice do not undergo agrin-mediated
6A and data not shown). Specific binding of MuSK±Fc AChR clustering provided the first evidence that MuSK
to myotube surfaces, in the absence of exogenously was absolutely required for agrin responsiveness but,
provided agrin, may indicate that MuSK has an affinity because clustering occurs over a period of hours, did
for its myotube-specific accessory component in the not address whether MuSK was acting proximally or
absence of ligand. Alternatively, since myotubes make distally in the agrin-signaling pathway. Assays for induc-
muscle forms of agrin (lacking the 8 amino acid insert tion of MuSK tyrosine phosphorylation yielded results
at the Z position), the specific binding of MuSK±Fc to consistent with the notion that MuSK acted proximally
myotubes in the absence of added agrin could be ex- as the direct receptor for agrin, since agrin induced
plained by the formation of a complex between the MuSK phosphorylation with the kinetics characteristic
added MuSK±Fc and endogenously expressed muscle of ligands for RTKs; furthermore, agrin acted with a
agrin along with the accessory component; adding addi- specificity profile and concentration dependence that
tional exogenous soluble agrin may simply allow for
would be expected if it were the MuSK ligand. However,
even more MuSK to be recruited into complexes with
we were able to demonstrate that agrin does not bind
the myotube-specific accessory component. Although
to the purified MuSK ectodomain. This finding led us to
both myoblasts and myotubes make endogenous agrin,
consider the possibility that in order for agrin to interact
myoblasts seemingly cannot form complexes with
with MuSK, it requires an accessorycomponent(s). Moti-
added MuSK±Fc since they do not express the required
vated by this possibility, we proceeded to demonstrateaccessory component.
that agrin-induced MuSK phosphorylation depends onTo confirm that MuSK directly interacts with agrin as
an accessory component expressed in differentiatedpart of its receptor complex, we next demonstrated that
myotubes but not in fibroblasts or undifferentiated my-radiolabeled agrin could be cross-linked to MuSK recep-
oblasts. Furthermore, we were able to form complexestors on the surface of myotubes. Immunoprecipitations
between agrin and soluble versions of the MuSK ectodo-using a MuSK-specific antibody, from lysates of myo-
main, but only in the presence of the accessory compo-tubes chemically cross-linked to radiolabeled recombi-
nent(s) found on the surface of myotubes (see Figurenant human agrin (Valenzuela et al., unpublished data),
5C); agrin directly binds to MuSK in this receptor com-contained complexes corresponding in size to agrin/
plex, as demonstrated by cross-linking analysis usingMuSK complexes (Figure 6B). These agrin/MuSK com-
radiolabeled agrin. Finally, as would be predicted fromplexes were not seen in the presence of excess unla-
our observation that soluble MuSK could form com-beled agrin, or if a peptide was used to block MuSK
plexes with the accessory component on the surfaceprecipitation (Figure 6B). Additional radiolabeled spe-
of myotubes, excess soluble MuSK could apparentlycies that immunoprecipitated with the MuSK antibody
sequester this accessory component and inhibit agrincorrespond to forms of agrin that are associated with,
responses. Altogether our data indicate that MuSK is abut not cross-linked to, MuSK, presumably due to the
requisite subunit of a multicomponent receptor complexlow efficiency of cross-linking (Figure 6B); low levels of
used by agrin, and that it requires a myotube-specificadditional agrin complexes, perhaps involving MASC,
accessory component(s) to bind and mediate responsescould also be detected in these immunoprecipitations.
to agrin.Finally, if our findings that soluble MuSK could form
There are many other examples of ligands that usecomplexes with its requisite myotube-specific acces-
multicomponent receptor complexes (Stahl and Yanco-sory component are correct, then this soluble receptor
poulos, 1993). Most cytokines, as noted above for CNTFshould also act as an inhibitor of agrin-mediated re-
and its relatives, use such receptor complexes. In thesesponses by sequestering the accessory component and
receptor complexes there are often components whosepreventing it from interacting with the endogenously
primary role is to bind ligand, whereas other subunitsexpressed, signaling-competent MuSK. Indeed, addi-
can both bind and signal. In the case of RTKs, theretion of increasing amounts of MuSK±Fc did inhibit agrin-
are also examples of multicomponent receptors. Formediated clustering of AChRs (Figure 6C) as well as
example, FGFs need to bind heparin, usually presentedagrin-induced MuSK phosphorylation (data not shown)
on surface proteoglycans, in order to bind and activatein a dose-dependent manner, while control receptor±Fc
proteins had no inhibitory effect. their RTK subunits (Goldfarb, 1990). The Trk family of
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RTKs, which bind to nerve growth factor (NGF) and the agrin to bind dystroglycan as well as to induce AChR
related neurotrophins, present a less well-understood clustering are both calcium dependent. In addition, al-
example of RTKs that may interact with an accessory though dystroglycan may not correspond to the critical
component known as p75 (Barbacid, 1993). In the case accessory component required for agrin to activate
of ARIA/neuregulin, receptor complexes can include two MuSK, it may still play a more passive ancillary role by
different members of the ErbB family (Burden et al., concentrating agrin on the muscle surface and helping
1995). In all these examples of multicomponent receptor present it to the MuSK receptor complex. In any case,
complexes, signal initiation seems to depend on ligand- a-dystroglycan certainly appears to be the most abun-
mediated dimerization of signal-transducing subunits dant agrin receptor, and may well be obscuring lower
that are included within the receptor complex; this di- levels of the requisite accessory receptor for MuSK.
merization can involve either homodimerization of iden- Since MuSK apparently does not bind agrin in the ab-
tical subunits, or heterodimerization of related subunits. sence of the accessory component, previous biochemi-
cal approaches to isolate agrin-binding proteins (involv-
The Myotube-Associated Specificity ing extraction and isolation of proteins from the cell
Component, MASC surface) would not have been expected to have identi-
Before considering potential candidates for the other fied isolated MuSK as an agrin-binding protein.
component(s) of the agrin receptor complex, it is worth There are other clues concerning the possible identity
remembering that the signaling function of MuSK ap- of accessory receptor components for agrin. Recent
pears quite unusual as compared with other RTKs. While data implicate a synapse-specific carbohydrate in agrin
most RTKs are thought to mediate growth or survival responses (Martin and Sanes, 1995); enzymatic removal
responses, or rather simple differentiative events, MuSK of this carbohydrate blocks agrin responsiveness,
seems instead to mediate a very complicated organizing whereas lectin-mediated clustering of proteins with this
function. The structure of the NMJ has already been carbohydrate, or enzymatic unmasking of more of this
shown to depend on complex molecular scaffolds that carbohydrate, potentiate or even mimic agrin. These
anchor components in place, by linking them to the data could be reconciled with the concept of a MuSK
extracellular matrix as well as to the cytoskeleton. Since receptor complex if such a carbohydrate marked and
they combine to initiate formation of the entire postsyn- was required for agrin recognition by the MuSK acces-
aptic macrostructure, and also are contained within it,
sory component. Alternatively, it could be that such a
it seems likely that both agrin and MuSK will have many
carbohydrate is required on MuSK itself. Along these
interactions with molecules at the NMJ, for both struc-
lines, it should be pointed out that a myotube-specific
tural and signaling purposes. One can imagine that
modification of MuSK, whether it involves carbohydrate
MuSK interacts with proteins that serve to link it to the
or other modifications, may allow MuSK to directly bind
molecular scaffold at the junction, both extracellu-
agrin, and thus raises the possibility that modified MuSKlarly and intracellularly; it may bind to other proteins that
itself might correspond to the myotube-specific ªacces-are direct substrates for its kinase activity, or that act
soryº component; in this case, soluble recombinantmerely as couplers of MuSK to its substrates. Thus, the
MuSK would presumably be able to dimerize with themyotube-specific accessory component(s) required for
correctly modified MuSKÐvia agrinÐon the myotubeagrin to bind and activate MuSK may be difficult to
surface. A related scenario might involve the expressiondistinguish from other (perhaps more abundant) mole-
of a MuSK relative in myotubes, and the need for hetero-cules interacting with agrin and MuSK that serve other
dimerization between MuSK and this relativeÐas canfunctions; even the accessory component(s) itself may
occur with the ErbBsÐto create a functional agrin re-be multifunctional, and serve not only to help bind agrin,
ceptor. Finally, since agrin forms lacking the ability tobut to couple this ligand/receptor system to other pro-
bind heparin arestill active, it seems unlikely that bindingteins as well.
to a proteoglycan at the Y site would be critical forDoes a-dystroglycan correspond to the accessory
linking agrin to its accessory component.component required for agrin to activate MuSK? Al-
though it satisfies the criterion of being able to bind to
Mechanism by Which MuSK Activationforms of agrin both with and without the 8 amino acid
Triggers Postsynaptic Organizationinsert at the Z position, several pieces of data strongly
Previous studies had implicated tyrosine phosphoryla-argue against a-dystroglycan as the sole accessory
tion in the agrin response (Wallace et al., 1991; Qu andcomponent. Most importantly, a-dystroglycan is widely
Huganir, 1994; Wallace, 1994, 1995; Ferns et al., 1996).expressed on many cell types, including on myoblasts
The finding that the critical signaling component of theand fibroblasts, so it is not myotube specific. In addition,
agrin receptor complex is an RTK validates the notionrecent findings that the dystroglycan complex does not
that specific agrin-induced tyrosine phosphorylationscluster at the endplate in rapsyn-deficient mice (Gautam
initiate organization and formation of the NMJ. The onlyet al., 1995) suggests that MuSK activation can be un-
well-characterized agrin-induced tyrosine phosphoryla-coupled from dystroglycan coclustering, since several
tion, other than that of MuSK, is of the AChR b compo-aspects of agrin/MuSK-mediated signaling (including
nent (Wallace et al., 1991; Qu and Huganir, 1994; FernsMuSK clustering) remain intact in these mice. However,
et al., 1996). As would be expected, although phosphor-since AChRs do not cluster in rapsyn-deficient mice,
ylation of AChRb is relatively rapid and begins by 15the dystroglycan complex may well play a required role
min after agrin addition, it trails MuSK phosphorylation.in coupling MuSK activation to AChR clustering, per-
It is unknown whether AChRb phosphorylation is re-haps even via its shared binding toagrin; such a possibil-
ity would nicely explain the finding that the ability of quired or contributes to AChR clustering, or whether it is
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521
a direct substrate of MuSK. The critical MuSK-mediated of muscular dystrophies (Campbell, 1995). The mecha-
nism by which problems in the dystroglycan complexphosphorylations may well involve proteins that are
clustered or directly involved in building the molecular lead to progressive muscle wasting are poorly under-
stood, and efforts to understand this mechanism arescaffold that maintains the postsynaptic specialization.
It is easy to imagine that direct phosphorylation of key primarily focused on problems with sarcolemmal stabil-
ity. The association of an RTK with the dystroglycanproteins may trigger complexes or aggregations to
formÐfor example, AChRb phosphorylation may trigger complex would certainly raise the possibility that signal-
ing defects could play an important contributory role inits association and coaggregation with rapsyn or other
coupling proteins. Since MuSK appears to be much less dystrophies. Interestingly, in humans, MuSK overlaps
with the region reported to contain the Fukuyama mus-abundant than many of the proteins that are clustered,
it would presumably act catalytically on such struc- cular dystrophy mutation.
tural targets. Alternatively, MuSK-mediated phosphory-
Experimental Procedureslations may not directly trigger clustering events, but
rather MuSK may activate downstream enzymes or sig-
Transient and Stable Transfections of Agrin- andnaling pathways that in turn trigger clustering. These
MuSK-Encoding Plasmids into COS
possibilities emphasize the need to identify direct sub- and C2C12 Cell Lines
strates and signaling pathways activated by MuSK. Transient transfections using either previously described agrin con-
structs (Ferns et al., 1993) or empty vector controls, or stable trans-
fections of a chick MuSK-expression construct (Glass et al., unpub-
lished), were performed as described (Glass et al., 1991; Ip et al.,MuSK Signaling in Other Contexts: in the
1992). Agrin concentrations in conditioned media derived from tran-Adult, Atrophies and Dystrophies?
sient transfections were estimated by immunoblot comparisons withThe complex type of organizational role played by MuSK
purified agrin of known concentration.
at the NMJ distinguishes it from other growth factors
that use RTKs. However, this unusual role does not AChR-Clustering Assays on MuSK2/2 Myotubes and
preclude MuSK from having more traditional growth fac- on C2C12 Myotubes
Primary myoblastcultures were established from hind limb muscula-tor±like effects. Exploration of the signaling pathways
ture of newborn MuSK2/2 or littermate control pups. This tissueactivated by MuSK will certainly help address whether
was treated sequentially with collagenase and trypsin, then platedMuSK uses unique signaling pathways, or instead
onto plastic tissue culture dishes. After 1 hr, nonadherent cells (prin-shares pathways with other RTKs. When it was realized
cipally myoblasts) were removed and plated onto chamber slides
that the Trk family of RTKs served as the receptors for coated with poly-D-lysine and fibronectin. Myoblast cultures were
nerve growth factor and its relatives, it was thought maintained in Dulbecco's modified Eagle's medium (DMEM) con-
taining 25% fetal calf serum, 10% horse serum, and 50 mg/ml genta-that the Trks might prove to have unusual substrates
mycin. To induce myotube formation, cultures were switched to abecause they mediated neuronal survival and differenti-
medium consisting of DMEM containing 5% horse serum, L-gluta-ation responses, as opposed to the conventional type
mine and gentamycin to which 20 mM cytosine arabinoside wasof proliferative responses that had previously been at-
added after 24 hr. After an additional 2-3 days, contractile myotubes
tributed to RTKs. It turns out, instead, that the Trks had formed abundantly in cultures from both MuSK2/2 and control
activate much the same substrates as mitogenic RTKs, pups. C2C12 cells were maintained and caused to differentiate in
a serum-poor medium as previously described (Ferns et al., 1993).but that these activations are ultimately interpreted
For agrin-mediated AChR clustering assays on primary myotubes,much differently within the context of a postmitotic neu-
cultures on chamber slides were treated overnight with c-agrin4,8 atron (Glass and Yancopoulos, 1993). In fact, ectopic ex-
0.01-100 nM; for evaluating MuSK-Fc as an inhibitor of clustering,pression of the Trks in proliferation-competent cells,
differentiated C2C12 cells, on chamber slides coated with fibronec-
such as fibroblasts, allows them to mediate conven- tin and poly-D-lysine, were pretreated with MuSK-Fc or a control
tional mitogenic responses indistinguishable from those receptor-body (at the indicated concentrations) for 1 hr at 378C
before addition of z10 nM agrin4,8 for overnight incubation. Follow-of FGFs or epidermal growth factors (Glass et al., 1991).
ing overnight treatments with agrin, the cells were next incubated inThus, it will be important to determine whether the un-
rhodamine-conjugated a-bungarotoxin (BGT) to label AChRs, thenusual actions of MuSK are a consequence of unique
fixed and mounted for fluorescence microscopy. To quantify thesignaling capabilities or simply its unique site of ex-
extent of AChR clustering, we viewed randomly selected myotubes
pression. under fluorescein optics, then switched to rhodamine optics and
Current studies of agrin and MuSK have almost com- counted the number of AChR clusters within a reticule grid aligned
along the long axis of the myotube.pletely focused on their roles during formation of the
AChRs on the surface of cultured primary myotubes were quanti-NMJ. In the entirely different context of an adult muscle,
tated by incubating live cultures with 25 mCi 125I-a-BGT for 1 hr atMuSK is dramatically upregulated in situations where
room temperature, washing, and then lysing the cells in 0.1 N NaOH.the muscle is at risk for atrophy, including during forced
The protein concentration in aliquots of each extract was deter-
immobilization (Valenzuela et al., 1995). It will certainly mined using a BCA protein assay kit (Pierce), while the remainder
be of interest to determine what kinds of actions MuSK of the extract was counted in a gamma counter.
mediates in the context of an adult muscle, if these
could be more along the trophic types more usual for Receptor Tyrosine Phosphorylation Assays
The ability of various agrins and growth factors to induce MuSK oran RTK, and if these actions would be of benefit during
ErbB3 tyrosine phosphorylation, for the indicated times and at themuscle atrophy or other muscle diseases. Along these
indicated concentrations, was evaluated in primary rat myoblastslines, it is worth noting that MuSK, via agrin,now appears
and in either untransfected C2C12 myoblasts, or in C2C12 my-
to be linked to the dytroglycan complex. Mutations in oblasts stably transfected with a chick MuSK-expressing plasmid
at least three of the components of this complex (dys- (Glass et al., unpublished). The cells were challenged at confluence
in an undifferentiated state, or approximately 4-5 days after beingtrophin, emerin, and adhalin) account for different types
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induced to differentiate into myotubes in serum-poor media. After unlabeled counterpart. For cross-linking studies, 10 cm plates of
differentiated C2C12 myotubes were incubated in 1 nM of [125I]ag-challenge, the cells were lysed, the extracts subjected to immuno-
precipitation with receptor-specific antibodies, and then immu- rin4,8 in 1.5 ml of PBS containing 1% BSA and 1 mg/ml glucose in
the presence or absence of 150-fold excess unlabeled agrin4,8 fornoblotted with either receptor-specific or phosphotyrosine-specific
antibodies, using methods previously described (Stitt et al., 1995). 75 min at 48C. The cross-linking agent DSS (disuccinimidyl suberate)
was added to a final concentration of 0.2 mM and the plates werePolyclonal antibodies for MuSK were generated as follows: for rat
MuSK, rabbits were immunized with a peptide corresponding to the incubated at room temperature for 30 min, washed 3 times with 50
mM Tris/150 mM NaCl (pH 7.5), lysed, and subjected to immunopre-carboxy-terminal 20 amino acids of the rat MuSK protein (Valenzuela
et al. 1995; our nomenclature for this antibody is: 41101K); for chick cipitation with MuSK-specific antibodies. For peptide competition,
peptide antigen was included in the immunoprecipitation at a finalMuSK, rabbits were immunized with a peptide corresponding to the
first 19 amino acids of the chick MuSK cytoplasmic domain (Glass concentration of 20 mg/ml. The samples were then electrophoresed;
fixed and dried gels were exposed for autoradiography.et al., unpublished; peptide: TLPSELLLDRLHPNPMYQ; our nomen-
clature for this antibody is 52307K). The specificity of the antibodies
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